SEC Form 4 · accession 0001493152-18-010156
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sara Bonstein
Officer — CFO/COO
Period of report
Jul 16, 2018
Accepted (ET)
Jul 18, 2018 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 16, 2018 | A | 625,000 | — | A | 625,000 | D | |
| Common StockF3 | Jul 16, 2018 | F | 135,485 | $1.34 | D | 489,515 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 16, 2018, the reporting person was awarded 625,000 RSUs pursuant to an employment inducement award. 312,500 of the RSUs vested and converted to ONCS stock on July 16, 2018, and the remaining 312,500 RSUs vest in equal quarterly installments over the next two years, such that the award will be fully vested on July 16, 2020.
- F2Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3In connection with the vesting of 312,500 RSUs on July 16, 2018, a total of 135,485 shares were withheld by the Company from such RSUs in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such withholding, which was conducted automatically in accordance with the issuer's corporate policies.